Literature DB >> 34061325

Melatonin and neuroblastoma: a novel therapeutic approach.

Mohammad Hossein Pourhanifeh1, Mahboobeh Kamali2, Saeed Mehrzadi3, Azam Hosseinzadeh4.   

Abstract

Neuroblastoma is a deadly and serious malignancy among children. Although many developments have been occurred for the treatment of this disease, the rate of mortality is still high. Therefore, it is necessary to search for novel complementary and alternative therapies. Melatonin, a hormone secreted from pineal gland, is a multifunctional agent having anticancer potentials. Recently, several investigations have been conducted indicating melatonin effects against neuroblastoma. In this paper, we summarize current evidence on anti-neuroblastoma effects of melatonin based on cellular pathways.

Entities:  

Keywords:  Cancer; Melatonin; Neuroblastoma

Mesh：

Substances：

Year:  2021        PMID： 34061325     DOI： 10.1007/s11033-021-06439-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN： 0301-4851            Impact factor:   2.316


  44 in total

Review 1.  Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.

Authors:  Cormac Owens; Meredith Irwin
Journal:  Crit Rev Clin Lab Sci       Date:  2012 May-Jun       Impact factor: 6.250

Review 2.  Potential use of melatonin in skin cancer treatment: A review of current biological evidence.

Authors:  Mohammad Hossein Pourhanifeh; Mostafa Mahdavinia; Russel J Reiter; Zatollah Asemi
Journal:  J Cell Physiol       Date:  2019-01-07       Impact factor: 6.384

Review 3.  [The influence of melatonin on the immune system and cancer].

Authors:  Anna Gry Vinther; Mogens Helweg Claësson
Journal:  Ugeskr Laeger       Date:  2015-05-18

Review 4.  Melatonin: a "Higgs boson" in human reproduction.

Authors:  Svetlana Dragojevic Dikic; Ana Mitrovic Jovanovic; Srdjan Dikic; Tomislav Jovanovic; Aleksandar Jurisic; Aleksandar Dobrosavljevic
Journal:  Gynecol Endocrinol       Date:  2014-11-07       Impact factor: 2.260

Review 5.  Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.

Authors:  Lucas Moreno; Hubert Caron; Birgit Geoerger; Angelika Eggert; Gudrun Schleiermacher; Penelope Brock; Dominique Valteau-Couanet; Louis Chesler; Johannes H Schulte; Katleen De Preter; Jan Molenaar; Alexander Schramm; Martin Eilers; Tom Van Maerken; John Inge Johnsen; Michelle Garrett; Sally L George; Deborah A Tweddle; Per Kogner; Frank Berthold; Jan Koster; Giuseppe Barone; Elizabeth R Tucker; Lynley Marshall; Ralf Herold; Jaroslav Sterba; Koen Norga; Gilles Vassal; Andrew Dj Pearson
Journal:  Expert Opin Drug Discov       Date:  2017-06-26       Impact factor: 6.098

Review 6.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

Review 7.  Melatonin and pancreatic cancer: Current knowledge and future perspectives.

Authors:  Omid Reza Tamtaji; Naghmeh Mirhosseini; Russel J Reiter; Morteza Behnamfar; Zatollah Asemi
Journal:  J Cell Physiol       Date:  2018-09-19       Impact factor: 6.384

Review 8.  Broad targeting of angiogenesis for cancer prevention and therapy.

Authors:  Zongwei Wang; Charlotta Dabrosin; Xin Yin; Mark M Fuster; Alexandra Arreola; W Kimryn Rathmell; Daniele Generali; Ganji P Nagaraju; Bassel El-Rayes; Domenico Ribatti; Yi Charlie Chen; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Somaira Nowsheen; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Bill Helferich; Xujuan Yang; Gunjan Guha; Dipita Bhakta; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Dorota Halicka; Sulma I Mohammed; Asfar S Azmi; Alan Bilsland; W Nicol Keith; Lasse D Jensen
Journal:  Semin Cancer Biol       Date:  2015-01-16       Impact factor: 15.707

9.  Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.

Authors:  Janina Fischer; Alexandra Pohl; Ruth Volland; Barbara Hero; Martin Dübbers; Grigore Cernaianu; Frank Berthold; Dietrich von Schweinitz; Thorsten Simon
Journal:  BMC Cancer       Date:  2017-08-04       Impact factor: 4.430

Review 10.  Melatonin and non-small cell lung cancer: new insights into signaling pathways.

Authors:  Mohammad Hossein Pourhanifeh; Mehran Sharifi; Russel J Reiter; Abdoulhossein Davoodabadi; Zatollah Asemi
Journal:  Cancer Cell Int       Date:  2019-05-16       Impact factor: 5.722
View more
  2 in total

Review 1.  Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation.

Authors:  Xiaoli He; Yongkang Liao; Jing Liu; Shuming Sun
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

Review 2.  Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells.

Authors:  Russel J Reiter; Ramaswamy Sharma; Sergio Rosales-Corral; Walter Manucha; Luiz Gustavo de Almeida Chuffa; Debora Aparecida Pires de Campos Zuccari
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.